Clinical trial

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

NCT06368817

Drugs and interventions used in this trial

11 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

RADIATION · Unmapped registry intervention 3-Dimensional Conformal Proton Radiation Therapy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention 3-Dimensional Conformal Radiation Therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Biospecimen Collection Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Etoposide Normalized identity: etoposideView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Intensity-Modulated Proton Therapy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Intensity-Modulated Radiation Therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Lumbar Puncture Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Magnetic Resonance Imaging Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Questionnaire Administration Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Surgical Procedure Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-10-22

PhasePHASE2

Conditions

Basal Ganglia Germinomaunresolved

Diabetes Insipidusverified · MONDO: diabetes insipidus

Germinomaverified · MONDO: germinoma

Pineal Region Germinomaverified · MONDO: pineal region germinoma

Suprasellar Germinomaunresolved

Thalamic Germinomaunresolved

Interventions

3-Dimensional Conformal Proton Radiation TherapyRADIATION

3-Dimensional Conformal Radiation TherapyRADIATION

Biospecimen CollectionPROCEDURE

CarboplatinDRUG · verified · RxNorm: carboplatin

EtoposideDRUG · verified · RxNorm: etoposide

Intensity-Modulated Proton TherapyPROCEDURE

Intensity-Modulated Radiation TherapyRADIATION

Lumbar PuncturePROCEDURE

Magnetic Resonance ImagingPROCEDURE

Questionnaire AdministrationOTHER

Surgical ProcedurePROCEDURE

Sponsors & collaborators

Children's Oncology Grouplead sponsor

Mapped research locations

New YorkNew York, United States4 ChicagoIllinois, United States3 HoustonTexas, United States2 BostonMassachusetts, United States2 PhiladelphiaPennsylvania, United States2 DallasTexas, United States2 St LouisMissouri, United States2 MiamiFlorida, United States2 San AntonioTexas, United States2 MontrealQuebec, Canada2 MinneapolisMinnesota, United States2 OrlandoFlorida, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06368817 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.